Ostertagia / Brown Stomach Worm

Ostertagia, commonly known as the brown stomach worm, is the most economically important gastrointestinal parasite of cattle in temperate regions worldwide, causing a condition known as ostertagiosis that severely impacts growth rates, milk production, and overall animal productivity. The primary species affecting cattle is Ostertagia ostertagi, while Teladorsagia circumcincta, previously classified within the Ostertagia genus, is the corresponding species of greatest importance in sheep and goats. These parasites reside in the abomasum, the true stomach of ruminants, where they damage the gastric glands responsible for acid and enzyme production, fundamentally disrupting the digestive process and causing profound effects on nutrient absorption and metabolic function.

The condition occurs in two distinct clinical forms with different epidemiology and presentation patterns. Type I ostertagiosis develops during the grazing season when animals ingest large numbers of infective larvae from contaminated pastures, causing acute disease characterized by profuse watery diarrhea and rapid weight loss. Type II ostertagiosis, also known as winter ostertagiosis in the Northern Hemisphere, results from the mass emergence of larvae that have been dormant within the gastric glands, typically occurring in late winter or early spring months after arrest during the previous grazing season. Understanding these two disease patterns is essential for implementing effective prevention and treatment strategies.

The economic impact of ostertagia infection on cattle production is substantial, with estimates suggesting that subclinical infections alone reduce growth rates by fifteen to twenty-five percent even in the absence of obvious clinical disease. Clinical outbreaks can cause significant mortality in severely affected groups, while subclinical parasitism across entire herds or flocks results in reduced feed conversion efficiency, delayed finishing times, decreased milk yields in dairy cattle, and impaired reproductive performance. The welfare implications are equally concerning, with affected animals experiencing chronic discomfort, malnutrition, and reduced quality of life that may persist throughout the grazing season.

Early detection and strategic management of ostertagia infection are critical for minimizing both clinical losses and subclinical productivity impacts. Unlike some parasitic conditions where clinical signs only appear with very heavy infections, ostertagia causes significant production losses at infection levels that may not produce obvious illness. Integrated control programs combining strategic anthelmintic use with pasture management, monitoring through fecal egg counts, and selection for genetic resistance provide the most sustainable approach to managing this ubiquitous parasite. With appropriate intervention, prognosis for affected animals is generally good, though prevention remains far more cost-effective than treatment of established clinical disease.

The primary cause of ostertagiosis is infection with Ostertagia ostertagi in cattle or Teladorsagia circumcincta in sheep and goats, acquired through ingestion of infective third-stage larvae present on contaminated pastures. These nematode parasites have a direct lifecycle without intermediate hosts, with eggs passed in feces of infected animals developing through first and second larval stages to the infective third stage on herbage under appropriate environmental conditions. The complete free-living development typically requires two to four weeks under optimal warm, moist conditions, though development can be prolonged or suspended during cold or dry periods. Once ingested by a grazing ruminant, larvae penetrate the gastric glands of the abomasum where they undergo further development before emerging as adult worms.

A distinctive feature of ostertagia biology with critical clinical implications is the ability of larvae to undergo hypobiosis, a state of arrested development within the gastric glands that can persist for months before development resumes. Larvae ingested during late summer and autumn in temperate climates commonly enter this arrested state rather than completing immediate development, accumulating within the gastric mucosa over the grazing season. The triggers for resumed development are not fully understood but appear related to host physiological changes and environmental factors occurring in late winter and early spring. Synchronous emergence of large numbers of previously arrested larvae causes the dramatic clinical syndrome known as Type II ostertagiosis.

Environmental and management factors strongly influence the level of ostertagia challenge faced by grazing livestock. Stocking density is a primary determinant of pasture contamination, with heavily stocked fields accumulating higher larval burdens than extensively grazed areas. Permanent pasture systems without rest periods or rotation allow progressive buildup of contamination over successive grazing seasons. Wet, temperate climates provide optimal conditions for larval development and survival, with larvae able to persist for many months on herbage under favorable conditions. Microhabitat factors including sward height, shading, and moisture retention influence larval concentration in the grazing zone of pastures.

Risk factors for clinical ostertagiosis include immunological naivety in young stock experiencing their first grazing season, high pasture larval challenge from previous grazing by infected animals, and physiological stresses that impair immune competence. First-season grazing calves face highest risk because they lack acquired immunity and may be exposed to pastures contaminated by the previous year's grazers. Periparturient relaxation of immunity in cows around calving increases their susceptibility and contribution to pasture contamination during the critical early grazing period. Concurrent disease, inadequate nutrition, and other stressors may impair the immune response and worsen clinical outcomes.

The pathophysiology of ostertagia infection centers on damage to the abomasal mucosa and disruption of normal gastric function. Developing larvae burrow into the gastric glands, destroying the specialized acid-secreting parietal cells and pepsinogen-producing chief cells that line these structures. This damage reduces acid production, elevating abomasal pH from the normal highly acidic level to near neutral. The altered pH impairs protein digestion, allows bacterial proliferation in the normally sterile stomach, and increases gastrin production through loss of feedback inhibition. Plasma proteins leak through the damaged mucosa into the gut lumen causing hypoproteinemia, while the osmotic effects of undigested nutrients and the irritant effect of bacterial overgrowth combine to produce the characteristic profuse watery diarrhea.

Early warning signs of ostertagia infection in cattle may be subtle and easily attributed to other causes, particularly in the subclinical phase where productivity impacts occur without obvious illness. Affected animals may show slightly reduced appetite and spend less time grazing compared to their cohorts, though this can be difficult to detect without careful observation. Growth rates may fall below expected levels without dramatic weight loss, and producers may notice that certain groups require longer to reach target weights than in previous years. Coat condition may deteriorate gradually, with affected cattle developing rough, dull hair coats lacking normal shine. These subtle changes often precede the development of more obvious clinical signs by weeks to months.

The hallmark symptom of clinical ostertagiosis is the development of profuse, watery, dark green diarrhea that rapidly leads to dehydration and visible weight loss. This diarrhea is characteristically persistent and does not respond to changes in diet or management, distinguishing it from nutritional scours or other transient causes of loose feces. The feces may have a distinctive offensive odor and cause extensive soiling of the hindquarters, tail, and hocks. Affected cattle pass feces with increased frequency, often with apparent urgency and straining that reflects intestinal irritation. The combination of fluid loss through diarrhea and reduced nutrient absorption leads to rapid deterioration of body condition.

Behavioral changes in cattle with ostertagiosis reflect the systemic effects of abomasal dysfunction, protein loss, and metabolic derangement. Affected animals often stand separately from the herd with hunched posture and lowered head carriage, showing reluctance to move when disturbed. Appetite is markedly reduced or absent, with cattle refusing both grazing and supplementary feeds. Rumination frequency decreases as overall feed intake declines. In dairy cattle, milk production drops precipitously, often by fifty percent or more within a few days of clinical onset. Depressed demeanor and reduced interaction with herdmates are common observations.

Physical examination findings in cattle with clinical ostertagiosis include evidence of dehydration with sunken eyes, dry muzzle, and reduced skin elasticity assessed through skin tent testing. Marked weight loss may be apparent even over short periods, with visible prominence of skeletal structures including ribs, spine, and hip bones. Submandibular and ventral edema, commonly called bottle jaw and brisket edema respectively, develop in animals with significant protein loss and hypoproteinemia. Mucous membranes may appear pale reflecting anemia from chronic blood and protein loss. Auscultation reveals increased intestinal sounds during active diarrhea, while rumen motility may be reduced reflecting overall gastrointestinal dysfunction.

Symptom progression differs between Type I and Type II ostertagiosis, though the clinical picture when fully developed is similar. Type I disease develops during the grazing season with gradual onset as larvae are progressively ingested from pasture, though acute presentation can occur when naive animals encounter heavily contaminated pastures. Type II disease typically presents more acutely in late winter or early spring when massive numbers of previously arrested larvae emerge simultaneously from the gastric glands, overwhelming the animal's compensatory mechanisms over a period of days to weeks. Without treatment, both forms can progress to severe debilitation, recumbency, and death from metabolic derangement and secondary complications.

Emergency symptoms requiring immediate veterinary intervention include severe dehydration with markedly prolonged skin tent and cold extremities, complete anorexia with no interest in feed or water, recumbency with inability or unwillingness to rise, and signs of secondary complications such as pneumonia in debilitated animals. Profuse watery diarrhea continuing despite supportive care suggests ongoing active disease requiring intensified treatment. Any animal showing progressive deterioration despite initial treatment attempts requires urgent reassessment and consideration of alternative diagnoses or concurrent conditions. Young calves can deteriorate rapidly due to their limited metabolic reserves and may require emergency fluid therapy within hours of clinical onset.

Clinical examination for suspected ostertagiosis begins with thorough assessment of affected individuals combined with evaluation of herd-level patterns including age group affected, timing relative to grazing season, and numbers of animals involved. Physical examination documents hydration status, body condition score, evidence of edema, fecal consistency, and signs of anemia through mucous membrane assessment. Rectal temperature is typically normal or subnormal rather than elevated, helping differentiate parasitic disease from infectious enteritides that commonly cause fever. The combination of profuse watery diarrhea, rapid weight loss, and bottle jaw in grazing cattle during appropriate seasonal timing creates a clinical picture highly suggestive of ostertagiosis.

Diagnostic testing for ostertagia infection includes several approaches with different applications and limitations. Fecal egg counts using the McMaster or modified McMaster technique quantify strongylid eggs per gram of feces, providing an estimate of adult worm burden, though egg counts may be low or negative in Type II disease where clinical signs result from larval emergence rather than established adult populations. Plasma pepsinogen levels are elevated in ostertagiosis due to leakage from damaged gastric glands and provide useful confirmation of abomasal damage, with values above three international units per liter considered indicative of significant disease. Serum protein levels demonstrate hypoproteinemia and hypoalbuminemia reflecting intestinal protein loss. Post-mortem examination reveals characteristic moroccan leather appearance of the abomasal mucosa with visible nodular lesions representing gastric gland damage.

Differential diagnosis of diarrhea and weight loss in grazing cattle includes numerous conditions that may present similarly to ostertagiosis. Other gastrointestinal parasites including Cooperia and Trichostrongylus species cause similar clinical signs and commonly occur as mixed infections. Bovine viral diarrhea may present with acute or chronic diarrhea depending on immune status and viral strain. Salmonellosis and other bacterial enteritides cause acute systemic illness alongside diarrhea, typically with fever. Johne's disease causes chronic wasting and diarrhea in adult cattle. Nutritional causes including sudden feed changes, acidosis, and specific deficiencies should be considered. Coccidiosis primarily affects young calves and may present with bloody diarrhea.

Herd-level diagnostics support confirmation of ostertagiosis as a flock or herd problem and help guide control program development. Bulk or pooled fecal egg counts from representative animals in each management group provide an efficient screening method to assess overall infection pressure. Pasture larval counts, though labor-intensive, can quantify environmental challenge on specific fields. Analysis of production data including growth rates, milk yields, and reproductive performance may reveal subclinical productivity impacts attributable to parasitism. Slaughterhouse surveillance with examination of abomasa from culled animals provides valuable information about parasite burdens and species present on individual farms. Integration of diagnostic information with grazing history, treatment records, and environmental monitoring supports evidence-based control planning.

Emergency treatment of clinically affected cattle with ostertagiosis requires immediate anthelmintic administration combined with supportive care to address dehydration, electrolyte imbalances, and nutritional deficits. The cornerstone of treatment is administration of an effective anthelmintic drug at the appropriate dose for the animal's body weight. Macrocyclic lactone anthelmintics including ivermectin, doramectin, eprinomectin, and moxidectin are highly effective against both adult ostertagia and inhibited larvae, making them particularly valuable for Type II disease where arrested larvae are the primary pathology. Injectable formulations provide reliable dosing in animals that may be unwilling or unable to swallow oral preparations.

Medical management of ostertagiosis extends beyond anthelmintic treatment to address the metabolic consequences of abomasal damage and diarrhea. Fluid therapy is indicated for dehydrated animals, with oral electrolyte solutions suitable for mild to moderate dehydration and intravenous crystalloid fluids required for severely affected individuals. Provision of high-quality palatable feed encourages voluntary intake as appetite returns, though forced feeding should be avoided in cattle that are not eating voluntarily. Non-steroidal anti-inflammatory drugs may provide symptomatic relief and help reduce abomasal inflammation. Withdrawal times for all drugs administered to food-producing animals must be carefully observed and documented.

Surgical intervention is not applicable to ostertagiosis, as the condition involves diffuse mucosal damage rather than surgically correctable lesions. However, intensive nursing care plays a vital role in recovery of severely affected animals and should not be underestimated. Providing shelter from adverse weather reduces metabolic demands during recovery. Isolation of affected individuals allows close monitoring and prevents competition for resources with healthier herdmates. Soft bedding encourages recumbent animals to rest and reduces secondary injuries. Ensuring access to clean water at all times supports rehydration alongside any fluid therapy provided.

Supportive care measures for cattle recovering from ostertagiosis focus on nutritional rehabilitation and monitoring for complications. High-quality hay and palatable concentrates should be offered as appetite returns, with gradual reintroduction of full rations to avoid digestive upset. Protein supplementation helps replace plasma proteins lost through the damaged abomasal mucosa. Trace mineral and vitamin supplementation addresses any deficiencies that may have developed during the malabsorption phase. Probiotics may support restoration of normal ruminal and intestinal microbiota, though evidence for their efficacy in parasitic disease recovery is limited.

Herd treatment protocols should be implemented when ostertagiosis is diagnosed, as affected animals share exposure with others in the same grazing group. Metaphylactic treatment of the entire group reduces the risk of additional clinical cases and addresses subclinical infections that impair productivity without causing obvious illness. Choice of anthelmintic class should consider regional resistance patterns and the farm's drug usage history to minimize selection pressure for resistant parasites. For Type II ostertagiosis, treatment of at-risk groups before the anticipated period of larval emergence provides better outcomes than treatment of clinical cases as they develop.

Treatment decisions on cattle farms must balance individual animal welfare and recovery potential against economic considerations of commercial production. The value of recovered animals relative to treatment costs and expected productivity following recovery influences treatment intensity decisions. Severely affected animals with poor prognosis despite appropriate treatment may be candidates for humane euthanasia rather than prolonged treatment attempts. Residue withdrawal periods must be factored into marketing decisions for treated animals approaching slaughter. Documentation of treatments, withdrawal periods, and clinical outcomes supports both regulatory compliance and evaluation of program effectiveness. Prevention through strategic management remains more cost-effective than repeated treatment of clinical outbreaks.

Recovery timeline for cattle treated for ostertagiosis depends on disease severity at the time of treatment, the extent of abomasal damage, and the adequacy of supportive care during convalescence. Animals with mild to moderate disease treated promptly typically show clinical improvement within forty-eight to seventy-two hours, with diarrhea resolving and appetite returning as abomasal inflammation begins to subside. Complete resolution of clinical signs may take one to two weeks, while full recovery of abomasal function and return to normal digestive efficiency may require several weeks longer. Animals with severe disease or delayed treatment face longer recovery periods and may experience lasting effects on productivity.

Post-treatment care and monitoring of recovered cattle involves continued observation for recurrence of clinical signs, tracking of body condition and growth rates, and fecal egg count testing to confirm treatment efficacy and detect reinfection. Animals should ideally be moved to clean pastures following treatment to minimize immediate reexposure to infective larvae. Continued nutritional support with high-quality feed helps rebuild body condition lost during clinical disease. Regular weighing allows objective assessment of compensatory growth and identification of individuals that may be failing to thrive despite treatment. Recurrence of diarrhea or failure to improve following treatment should prompt veterinary reevaluation and consideration of alternative diagnoses.

Prognosis factors for individual animals recovering from ostertagiosis include the severity and duration of clinical disease before treatment, the degree of abomasal mucosal damage, the animal's age and nutritional status, and whether concurrent conditions are present. Young animals with acute disease treated promptly generally have excellent prognosis with minimal lasting effects. Older animals or those with chronic disease before treatment may have more extensive mucosal scarring that permanently impairs digestive efficiency. Animals that developed significant hypoproteinemia with edema require longer recovery periods for protein stores to normalize. Concurrent infections or nutritional deficiencies may slow recovery and worsen overall prognosis.

Return to production considerations for cattle recovered from ostertagiosis include assessment of growth potential relative to contemporaries, evaluation of residual effects on productivity, and decisions about retention versus culling. Animals that fully recover and demonstrate normal compensatory growth can continue through production programs without restriction once treatment withdrawal periods have elapsed. Those that fail to catch up with cohorts despite adequate nutrition may require extended feeding periods to reach market weights, with associated additional costs. Breeding stock selection should consider that severe parasitism during development may permanently affect an animal's lifetime productivity. Records of clinical disease and recovery performance inform future management and genetic selection decisions.

Vaccination protocols for ostertagia prevention are available in some regions, with irradiated larval vaccines providing partial protection by stimulating immunity without causing disease. These vaccines typically require two doses several weeks apart and provide protection for the following grazing season, reducing both clinical disease and productivity losses from subclinical infection. However, vaccination does not eliminate the need for other control measures and is most effective as part of an integrated program. Vaccine availability and regulatory approval vary between countries, and producers should consult with their veterinarians about local options and appropriate use protocols.

Biosecurity measures for ostertagia control focus on managing pasture contamination levels and preventing introduction of resistant parasite populations rather than preventing introduction of the ubiquitous parasite itself. Quarantine treatment of purchased cattle with effective anthelmintics before introduction to resident pastures reduces the risk of introducing drug-resistant parasites that could compromise control programs. New arrivals should graze separate pastures or be housed for sufficient time after treatment to pass any surviving eggs before mixing with resident stock. Fecal egg count reduction testing can identify animals carrying resistant parasites requiring alternative treatment approaches.

Nutritional prevention strategies support the immune system's ability to regulate parasite populations and mitigate the effects of infection. Adequate protein nutrition is particularly important, as protein-deficient animals show impaired immunity and greater susceptibility to clinical disease. Ensuring young stock have access to high-quality pasture and supplementary feeding during their first grazing season supports rapid development of acquired immunity. Trace mineral supplementation with selenium, copper, and cobalt supports immune function in deficient areas. Well-nourished animals can tolerate moderate parasite burdens with minimal clinical effect, while those in poor condition may develop severe disease from infections that would be subclinical in better-nourished individuals.

Management practices form the foundation of sustainable ostertagia control and include pasture management strategies to reduce larval challenge, grazing systems that minimize exposure of susceptible stock, and targeted anthelmintic use based on evidence of need. Pasture rotation with rest periods of two months or more allows significant larval die-off before animals return. Mixed grazing or alternate grazing with sheep utilizes the host specificity of bovine ostertagia to reduce contamination. Strategic grazing that places first-season calves on clean pastures while older immune cattle graze more contaminated areas protects the most vulnerable animals. Avoiding overgrazing maintains sward structure that reduces larval migration onto grazeable herbage.

Quarantine and testing protocols support both biosecurity and evidence-based treatment decisions. All incoming cattle should receive quarantine treatment with anthelmintics from multiple drug classes to maximize efficacy against any resistant parasites they may carry. Fecal egg count reduction testing following treatment identifies animals that may be carrying resistant worms requiring alternative approaches. Routine fecal egg count monitoring of representative animals from grazing groups allows targeted treatment of individuals or groups exceeding thresholds rather than blanket treatments that increase selection pressure for resistance. Documentation of treatment history, test results, and clinical observations supports continuous improvement of parasite management programs.

Daily management and monitoring for ostertagia control involves regular observation of grazing cattle for early signs of parasitism combined with systematic recording of observations to track trends. Stock persons should observe body condition, fecal consistency, coat quality, and general demeanor during routine checks. Any animals showing persistent diarrhea, failure to thrive, or edema should be examined more closely and considered for fecal testing or treatment. Regular weighing of young stock allows detection of subclinical growth check that may indicate parasitism before obvious clinical signs develop. Comparison of growth rates between contemporary groups identifies those that may be experiencing higher parasite challenge.

Housing and environmental management considerations include attention to pasture allocation, stocking density, and the timing of housing periods that influence ostertagia epidemiology. Strategic housing during periods of peak larval challenge can interrupt transmission and allow larvae on pasture to die off before animals return. Cattle brought into housing during late autumn will typically carry inhibited larvae that may emerge during the housed period, making strategic treatment at housing advisable. Attention to drainage, stocking density, and grazing pressure influences pasture contamination levels and the concentration of larvae in the grazing zone. Creep grazing systems that allow calves access to cleaner pastures while cows remain on more contaminated areas protect vulnerable young stock.

Herd health programs for cattle farms with ostertagia concerns should incorporate parasite monitoring and control as a core component of routine health management. Regular fecal egg count monitoring provides ongoing assessment of infection levels and guides treatment decisions. Plasma pepsinogen testing in late autumn indicates the level of inhibited larval burden and helps predict Type II ostertagiosis risk over winter. Anthelmintic resistance testing through fecal egg count reduction testing should be performed periodically to detect emerging resistance before clinical control failures occur. Integration of parasitology services with broader herd health activities maximizes information value and supports comprehensive planning.

Record keeping and monitoring systems support effective ostertagia management by documenting the information needed for evidence-based decisions. Essential records include pasture grazing records showing which groups used which fields, all anthelmintic treatments including products and dates, fecal egg count and pepsinogen results, and production data including growth rates and milk yields. Body condition scoring at regular intervals provides objective assessment of nutritional status. Records of clinical cases with presenting signs, treatments, and outcomes allow evaluation of control program effectiveness. Regular review of accumulated data with veterinary advisors identifies areas for improvement and guides strategic planning.

Economic considerations for ostertagia management encompass both the direct costs of prevention and treatment and the often-larger indirect costs of subclinical productivity losses. Subclinical ostertagiosis reduces growth rates by fifteen to twenty-five percent and milk yields by over one liter per day without obvious illness, representing substantial hidden losses. Economic analysis should compare the costs of control programs against projected productivity improvements from reduced parasitism. Targeted selective treatment approaches that treat only animals exceeding predetermined thresholds may reduce drug costs while maintaining adequate control, though increased labor for individual monitoring must be factored into calculations. Investment in diagnostic testing and professional advice typically provides positive returns through better-targeted interventions and improved outcomes.

High-risk breeds and populations for clinical ostertagiosis are defined primarily by exposure history and management system rather than inherent breed susceptibility, though genetic variation in parasite resistance exists within and between breeds. First-season grazing cattle of all breeds face highest risk because they lack acquired immunity and may encounter heavily contaminated pastures. Dairy breeds managed on permanent pasture with high stocking densities often experience greater challenge than extensively managed beef cattle on larger range areas. Indoor-raised calves suddenly turned out onto contaminated pasture are particularly vulnerable due to their complete lack of previous exposure and immunity.

Production type considerations significantly influence ostertagia risk through effects on management intensity, grazing system, and timing of marketing. Dairy replacement heifers raised on farm typically graze for multiple seasons before entering production, accumulating experience and immunity but also facing repeated challenge. Intensive beef finishing systems that complete the fattening phase indoors on conserved feeds avoid grazing season exposure during that period. Autumn-born calves may encounter different larval challenge patterns than spring-born calves due to the seasonality of larval availability. Breeding cattle retained for multiple years develop immunity that protects them from clinical disease but may maintain subclinical infections that contribute to pasture contamination.

Genetic selection and testing for ostertagia resistance is an active area of research, with evidence that animals differ in their ability to regulate parasite populations and resist the effects of infection. Fecal egg counts during natural grazing challenge can identify animals with inherently lower worm burdens that may pass this trait to offspring. Some breeding programs now include parasite resistance indices based on fecal egg count data, allowing selection of bulls whose progeny will be more resistant. Within-herd selection against animals that repeatedly require treatment for parasitism may gradually improve herd resistance over generations. However, resistance traits must be balanced against other production characteristics in breeding decisions, and genetic approaches complement rather than replace management-based control.

Commonly co-occurring conditions with ostertagia infection include other gastrointestinal parasites that share pasture-based transmission and similar epidemiology. Mixed infections with Cooperia species are particularly common, with these intestinal parasites often found alongside abomasal ostertagia in grazing cattle. Trichostrongylus axei affects the abomasum similarly to ostertagia and may contribute to the overall parasitic gastroenteritis syndrome. Dictyocaulus viviparus, the bovine lungworm, shares similar pasture epidemiology and may cause concurrent respiratory disease. Liver fluke infection with Fasciola hepatica occurs in cattle grazing wet pastures and adds hepatic damage to gastrointestinal parasitism. These concurrent infections often produce more severe disease than single-species infections alone.

Conditions with similar clinical presentations to ostertagiosis include various causes of diarrhea, weight loss, and hypoproteinemia in cattle that must be differentiated diagnostically. Johne's disease caused by Mycobacterium avium subspecies paratuberculosis produces chronic progressive wasting and diarrhea in adult cattle, though without the seasonality of Type II ostertagiosis. Bovine viral diarrhea may cause acute or chronic presentation depending on viral strain and immune status. Salmonellosis produces acute systemic illness with fever alongside diarrhea. Winter dysentery causes explosive outbreaks of diarrhea in housed cattle. Protein-losing enteropathies from other causes may produce edema similar to that seen in parasitic hypoproteinemia.

Complications and sequelae of ostertagia infection include both immediate and long-term consequences for affected cattle. Acute complications include severe dehydration and electrolyte imbalances that can cause cardiovascular collapse in untreated animals. Secondary pneumonia may develop in debilitated recumbent cattle. Chronic consequences include persistent reduction in digestive efficiency due to abomasal scarring that impairs gastric function even after parasites are eliminated. Animals that survive severe clinical disease often fail to reach their genetic potential for growth or production. Reproductive performance may be impaired in breeding cattle that experienced significant parasitism during development. Economic losses continue through reduced productivity and potentially shortened productive lifespan even in animals that survive clinical disease.